Latest News

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen




A new study by researchers from the Scripps Research Institute and Novavax Inc. in the US affirms the structural integrity of the full-length SARS-CoV-2 spike glycoprotein immunogen. It enables the interpretation of immune responses to this multivalent nanoparticle immunogen. Their results are currently available on bioRxiv preprint server.

Source link

Related posts

This Year’s Total Solar Eclipse And The Science Behind It

Newsemia

Telltale Signs You Have Tapeworm In Your Body

Newsemia

Stellar populations from spectroscopy of a large sample of quiescent galaxies at z > 1: Measuring the contribution of progenitor bias to early size growth

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World